Oncology

Buy Vemurafenib 240 mg tablets in Mumbai and Delhi with patient-specific supply across India

Oncology

September 7, 2026

Vemurafenib Availability in Mumbai and Delhi With India-Wide Supply

For patients undergoing treatment for advanced melanoma, timely access to targeted therapies can be an…

Dr. Banisetti Sravya

FDA-approved zanidatamab treatment for HER2-positive gastroesophageal adenocarcinoma and zanidatamab price in India

Oncology

September 1, 2026

FDA Approves Zanidatamab-Based Regimens for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

On August 25, 2026, the U.S. Food and Drug Administration (FDA) approved zanidatamab (Ziihera) in…

Dr. Purva Bhandari

The Complete Guide to Understanding Adagrasib

Oncology

August 27, 2026

The Complete Guide to Understanding Adagrasib

You try to convince yourself when your doctor prescribes Krazati and think you are on…

Dr. Banisetti Sravya

Oncology

August 26, 2026

Olverembatinib in India: Treatment and Import Access for Patients

Being prescribed a new treatment for chronic myeloid leukemia (CML) can raise practical questions. Why…

Dr. Banisetti Sravya

Oncology

August 25, 2026

What to Pack for a Datopotamab Deruxtecan Infusion Day

Are you planning to go to the treatment center for the first time but not…

Dr. Banisetti Sravya

Oncology

August 22, 2026

Epcoritamab: 4 Warning Signs You Shouldn’t Brush Aside

The common approach towards symptoms is either ignoring it or panicking too much but neither…

Dr. Banisetti Sravya

Cancer Is Clever: Why Encorafenib Has a Backup Plan

Immunology Oncology

August 21, 2026

Cancer Is Clever. Here’s Why Encorafenib Has Backup

Cancer is smart enough to increase its population. Never expected, right? It doesn’t play by…

Dr. Banisetti Sravya

Oncology

August 11, 2026

Unable to Access Ivonescimab Locally? Understanding Access Options

Ivonescimab is an innovative bispecific antibody that has attracted global attention for its encouraging results…

Dr. Banisetti Sravya

Oncology

August 10, 2026

Is Blinatumomab Safe for Children? What Parents Should Know

Blincyto! Well, that’s a good medicine for leukemia patients but will it be safe for…

Dr. Banisetti Sravya

Oncology

August 10, 2026

Pemigatinib Treatment May Differ Even With the Same Cancer

Patient A and Patient B enter the oncology department. Both have a cancer that originated…

Dr. Banisetti Sravya

Oncology

June 25, 2026

Belzutifan (Welireg): Connecting Patients to Treatment Access

What is Belzutifan? Belzutifan, marketed as Welireg, is an innovative targeted therapy that has transformed…

Dr. Banisetti Sravya

Sotorasib (Lumakras) 120 mg Tablets in India

Oncology

June 24, 2026

Sotorasib (Lumakras) 120 mg Price in India – Access Affordable Treatment

Sotorasib, also known as AMG-510, is an acrylamide-derived KRAS inhibitor developed by Amgen. Due to…

Dr. Banisetti Sravya

Vemurafenib Availability in Mumbai and Delhi With India-Wide Supply

FDA Approves Zanidatamab-Based Regimens for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

The Complete Guide to Understanding Adagrasib

Olverembatinib in India: Treatment and Import Access for Patients

What to Pack for a Datopotamab Deruxtecan Infusion Day

Epcoritamab: 4 Warning Signs You Shouldn’t Brush Aside

Cancer Is Clever. Here’s Why Encorafenib Has Backup

Unable to Access Ivonescimab Locally? Understanding Access Options

Is Blinatumomab Safe for Children? What Parents Should Know

Pemigatinib Treatment May Differ Even With the Same Cancer

Belzutifan (Welireg): Connecting Patients to Treatment Access

Sotorasib (Lumakras) 120 mg Price in India – Access Affordable Treatment

Recent Posts

Categories

Product categories

Quick Links

Contact Us